Proveris Scientific expands research team with the addition of accomplished research scientist, Prateek Nath, Ph.D.

Proveris Scientific Corporation, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced Prateek Nath has joined as a research scientist in Proveris Scientific’s growing research team.

 

Prateek will perform a range of research activities to advance new technology platforms at Proveris. His focus will be to design and build a wide variety of research-grade prototypes and run experiments on these prototypes to generate proof statements for scientific hypotheses related to aerosol science, human physiology, and drug delivery. In addition, Prateek will actively participate in Proveris’s research collaborations with academic, industrial, and government organizations. 

Prateek holds a Ph.D. in solid mechanics and minors in applied mathematics and materials science from Brown University in Providence, Rhode Island. He earned his Master of Science in mechanical design and optimization from Indian Institute of Technology, Bombay, India, and his Bachelor of Science in mechanical engineering from University of Pune. Prior to joining Proveris, Prateek worked as a computational modeling engineer for Johnson and Johnson in Raynham, Massachusetts, as a research engineer for Bose Corporation in Framingham, Massachusetts, and as a postdoctoral research fellow for Oak Ridge National Laboratory in Oak Ridge, Tennessee. Prateek holds nine U.S. Patents and has authored multiple publications and conference presentations.

Proveris Scientific’s Founder and CEO, Dino Farina, commented, “I’m excited to have Prateek join the Proveris team. Prateek’s significant engineering experience from Oak Ridge National Laboratory, Bose Corporation, and J&J are perfect complements to Proveris’s advanced research focus on integrating human physiology, aerosol science, and drug delivery into better tools for predictive performance modeling of orally inhaled and nasal drug products.”

 

About Proveris Scientific

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TÜV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.

Maria Smith appointed as Director, Application and Business Development for Proveris Laboratories

Proveris Scientific Corporation, a leading provider of instrumentation and services to advance the science of aerosol and spray products, today announced the appointment of Maria L. Smith, M.Sc., to the newly established role of Director, Application and Business Development for Proveris Laboratories. This is a new position focused on addressing the rapid growth of the cGMP contract test services and the introduction of new technologies. 

Maria joins Proveris with more than 14 years of CDMO experience in the development and test of orally inhaled and nasal drug products (OINDPs). She has extensive experience in spray characterization, as well as working with customers on problem resolution and compliance. She has authored 10 publications on spray characterization and is well known across the industry for her professionalism, experience, and expertise.

Maria will help drive the growth of Proveris Laboratories contract test services through the expansion of new applications and technologies. In addition, she will serve as a liaison to regulatory agencies, industry groups, and customers to educate on new technology approaches and how they can be used to support in-vitro in-vivo correlation (IVIVC) and bioequivalence (BE).   

Proveris Scientific’s President, Chip Leveille, commented, “Maria’s fourteen years of laboratory experience in spray/particulate science (nasal and oral products) with leading CDMO’s brings a deep understanding of drug development and testing as it pertains to inhalation products. She has extensive knowledge of Proveris systems and particle characterization techniques to develop and characterize aerosol and spray delivered drug devices. We are excited to have Maria on board to further establish and enhance Proveris technologies as critical approaches to drug approval and product release.”

 

About Proveris Scientific

Proveris Scientific Corporation advances the science of respiratory drug delivery products by driving new technology development for high performance spray characterization, capture, and analysis, while leveraging its expertise, experience, and core technologies. With customer success as its central motivating force, Proveris Scientific adds value to a global customer base with “complete solutions” which include product innovation, technical services, systems, consumables, and educational training. Since its founding in 1995, the company has accelerated the development of top spray and aerosol drug products and has deployed its systems at more than 100 pharmaceutical development and manufacturing sites around the globe. Proveris’s systems are the industry standard and are used by the FDA, CFDA, and the pharmaceutical industry to generate submission-ready data. Proveris is certified to ISO 9001:2015 by TÜV Rheinland of North America, Inc., and has more than 20 patents issued on its technology.